R. Laurence Berkowitz, MD, Daniel I. Jacobs, MD, and Paul J. Gorman, MD. 
    Purpose:  Numerous brow fixation techniques have  evolved over the last ten years with the advent of endoscopic browplasty.   Most of these techniques rely upon a single loop of suture material (per side)  fixed to the cranium (implantable screws, bone tunnels, etc.), removable  percutaneous devices (pins, screws, or wires), or external sutures or  dressings.  These methods have a number of shortcomings including single  point fixation and a lack of reliability.  The Endotine™ (Coapt Systems, Palo    Alto, CA) is an implantable bioabsorbable fixation device designed to provide  intuitive, multi-point distributed tension and predictable brow fixation during  endoscopic browplasty.  The purpose of this study was to evaluate early  results in a series of endoscopic browplasty cases performed with the Endotine™  device.    
     
Materials and Methods:  The Endotine™ device  used in this study is comprised of polylactic acid.  The device consists  of a post that is inserted into the cranium (4.25 mm), a platform (1.0 mm), and  a series of five tines projecting cephalad from this platform (3.5 mm).   These tines serve to puncture the periosteum and galea, thus securing the  elevated brow.  On a consecutive series of endoscopic browplasty cases,  pre- and post-operative standardized photographs in Frankfort horizontal were  obtained and three measurements were compared (mid-pupil to superior brow,  mid-pupil to hairline, and lateral canthus to superior brow).      
     
Results:  A total of 14 patients (thirteen  female and one male) underwent endoscopic browplasty.  Pre-operative  photographs were obtained within one month of the procedure, and follow-up  photographs were taken at 54 to 174 days (avg. 109) post-operatively.  The  following average brow elevation measurements (mm) were obtained:    
            |       | Pre-operative     | Post-operative     | Elevation ± SD     | 
       | Mid-pupil to superior    brow     | 22.4     | 26.7     | 4.52 ± 2.66     | 
       | Mid-pupil to hairline     | 76.5     | 81.4     | 4.63 ± 2.12     | 
       | Lateral canthus to sup.    brow     | 23.5     | 27.5     | 4.23 ± 2.4     | 
  
 
         
No significant adverse events were encountered in the  follow-up period.  A sample pre- and post-operative image set is shown in  Figures 1 and 2.    
     
 
    
Figure 1:  Pre-operative.    
 
    
Figure 2:  Post-operative (60 days).    
     
Conclusions:  The Endotine™ device provides significant  and reproducible brow elevation with no significant adverse events as measured  at three points in excess of fifteen weeks post-operatively.